iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://doi.org/10.1007/978-3-662-45139-7_142
Hormonal Treatment for Skin Androgen-Related Disorders | SpringerLink
Skip to main content
Springer Nature Link
Log in

Hormonal Treatment for Skin Androgen-Related Disorders

  • Chapter
European Handbook of Dermatological Treatments

Abstract

It is well known that the pilosebaceous unit is an elective androgen target tissue. In some areas of the skin, pilosebaceous units respond to androgens by forming sexual hair follicles, whereas in other areas they respond by forming sebaceous glands. Excessive androgen levels as well as their excessive local action on pilosebaceous units in different areas of the body may lead to different skin androgen-related disorders: hirsutism, acne, and androgenetic alopecia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

17β-HSD:

17β-Hydroxysteroid dehydrogenase

3β-HSD:

3β-Hydroxysteroid dehydrogenase

AGA:

Androgenetic alopecia

DHEAS:

Dehydroepiandrosterone sulfate

DHT:

Dihydrotestosterone

DHT:

Dihydrotestosterone

FPHL:

Female pattern hair loss

MPHL:

Male pattern hair loss

OC:

Oral contraceptives

PCOS:

Polycystic ovarian syndrome

PSA:

Prostate-specific antigen

SHBG:

Sex hormone-binding globulin

References

  • Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, Pugeat M, Qiao J, Wijeyaratne CN, Witchel SF, Norman RJ. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;18(2):146–70.

    Article  CAS  Google Scholar 

  • Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH. Classification and pharmacology of progestins. Maturitas. 2003;46 Suppl 1:S7–16.

    Article  CAS  Google Scholar 

  • Sitruk-Ware R. New progestogens: a review of their effects in perimenopausal and postmenopausal women. Drugs Aging. 2004;21(13):865–83.

    Article  CAS  Google Scholar 

Further Reading

  • Atanaskova Mesinkovska N, Bergfeld WF. Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment. Dermatol Clin. 2013;31(1):119–27.

    Article  CAS  Google Scholar 

  • Banka N, Bunagan MJ, Shapiro J. Pattern hair loss in men: diagnosis and medical treatment. Dermatol Clin. 2013;31(1):129–40.

    Article  CAS  Google Scholar 

  • Blume-Peytavi U, Atkin S, Gieler U, Grimalt R. Skin academy: hair, skin, hormones and menopause – current status/knowledge on the management of hair disorders in menopausal women. Eur J Dermatol. 2012;22(3):310–8.

    CAS  PubMed  Google Scholar 

  • Bode D, Seehusen DA, Baird D. Hirsutism in women. Am Fam Physician. 2012;85(4):373–80.

    PubMed  Google Scholar 

  • Bulun SE, Adashi EY. The physiology and pathology of the female reproductive axis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, editors. Williams textbook of endocrinology. 11th ed. Philadelphia: Saunders; 2011. p. 572–89. Chapter 16.

    Google Scholar 

  • Dawson AL, Dellavalle RP. Acne vulgaris. BMJ. 2013;346:f2634.

    Article  Google Scholar 

  • Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36.

    Article  CAS  Google Scholar 

  • Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4:1.

    Article  Google Scholar 

  • Essah PA, Wickham 3rd EP, Nunley JR, Nestler JE. Dermatology of androgen-related disorders. Clin Dermatol. 2006;24(4):289–98.

    Article  Google Scholar 

  • Harper JC. Hormonal therapy for acne using oral contraceptive pills. Semin Cutan Med Surg. 2005;24(2):103–6.

    Article  CAS  Google Scholar 

  • Harper JC. Should dermatologists prescribe hormonal contraceptives for acne? Dermatol Ther. 2009;22(5):452–7.

    Article  Google Scholar 

  • Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? Facts and controversies. Clin Dermatol. 2010;28(1):17–23.

    Article  Google Scholar 

  • Lakshmi C. Hormone therapy in acne. Indian J Dermatol Venereol Leprol. 2013;79(3):322–37.

    Article  Google Scholar 

  • Loriaux DL. An approach to the patient with hirsutism. J Clin Endocrinol Metab. 2012;97(9):2957–68.

    Article  CAS  Google Scholar 

  • McElwee KJ, Shapiro JS. Promising therapies for treating and/or preventing androgenic alopecia. Skin Therapy Lett. 2012;17(6):1–4.

    CAS  PubMed  Google Scholar 

  • Price VH. Treatment of hair loss. N Engl J Med. 1999;341(13):964–73.

    Article  CAS  Google Scholar 

  • Rosenfield RL. Clinical practice. Hirsutism N Engl J Med. 2005;353(24):2578–88.

    Article  CAS  Google Scholar 

  • Schindler AE. Differential effects of progestins on hemostasis. Maturitas. 2003;46 Suppl 1:S31–7.

    Article  CAS  Google Scholar 

  • Shapiro J. Clinical practice. Hair loss in women. N Engl J Med. 2007;357(16):1620–30.

    Article  CAS  Google Scholar 

  • Sinclair RD, Dawber RPR. Androgenetic alopecia in men and women. Clin Dermatol. 2001;19(2):167–78.

    Article  CAS  Google Scholar 

  • Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update. 2006;12(2):169–78.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sexual Medicine and Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

    Francesco Lotti & Mario Maggi

Authors
  1. Francesco Lotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Maggi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Lotti .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Andreas Syggros Hospital University of Athens, Athens, Greece

    Andreas D. Katsambas  & Clio Dessinioti  & 

  2. University of Rome “G. Marconi”, Rome, Italy

    Torello M. Lotti

  3. Centro Studi per la Ricerca Multidisciplinare Rigenerativa (CSRMR), Rome, Italy

    Torello M. Lotti

  4. Unit of Dermatology, University of Pisa, Pisa, Italy

    Angelo Massimiliano D’Erme

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lotti, F., Maggi, M. (2015). Hormonal Treatment for Skin Androgen-Related Disorders. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_142

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45139-7_142

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45138-0

  • Online ISBN: 978-3-662-45139-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation